Kapinac-Sera Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyresis through central inhibition of prostaglandin synthesis without significant anti-inflammatory activity. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation, enhancing tissue repair. This synergistic combination is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative inflammation, and soft tissue injuries. Kapinac-Sera Tablet offers rapid and sustained relief from pain and inflammation while aiding in the reduction of swelling and improving functional recovery. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active peptic ulcer disease, or severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risks. Adverse effects may include gastrointestinal discomfort, allergic reactions, or mild hepatic enzyme elevations. Patient adherence to prescribed dosing and monitoring is essential to optimize therapeutic outcomes and minimize potential risks.